ArticleBMJ (Clinical research ed.)2018

Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis.

Joshua D Wallach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.